Poor adherence to South African guidelines for the tnanagement of community-acquired pneumonia by Nyamande, K & Lalloo, UG
ORIGINAL ARTICLES
601
August 2007, Vol. 97, No. 8  SAMJ
The choice of antibiotics in the initial treatment of community-
acquired pneumonia (CAP) should cover the most likely 
pathogens and the pathogens most likely to cause severe 
disease. Guidelines have been published by a number of 
thoracic societies including the American Thoracic Society 
(ATS)1 and the Working Groups of the South African 
Pulmonology Society and the Antibiotic Study Group of South 
Africa.2
Few studies have been conducted to confirm whether 
guidelines are being adhered to, or whether adherence to 
recommendations leads to improved patient outcomes as 
determined by cost effectiveness, length of hospital stay 
and patient survival.3,4  Guidelines have not been validated 
prospectively.5 Continuing medical education may have 
little effect on physician practice.6-8 Published guidelines are 
therefore difficult to implement.
Use of macrolides as part of an initial therapeutic regimen 
appears to be associated with shorter length of hospital 
stay but has no effect on mortality.9 Initial treatment with 
a second-generation cephalosporin plus a macrolide, or a 
fluoroquinolone alone may be associated with lower 30-
day mortality compared with patients treated with a non-
pseudomonal third-generation cephalosporin alone.10  
Patients and methods
The study was conducted between June 2000 and October 2001. 
The admitting physician determined the initial antibiotic(s) 
administered.  Severe CAP was defined as the presence of two 
or more of the following: age greater than 60 years, co-morbid 
disease (neoplastic disease, chronic renal failure, chronic liver 
disease, diabetes mellitus, heart failure), confusion, cyanosis, 
systolic blood pressure < 90 mmHg or diastolic blood pressure 
< 60 mmHg, respiratory rate ≥ 30 breaths/min, temperature > 
38.3oC, involvement of 2 or more lobes on the chest radiograph, 
partial pressure of arterial oxygen < 60 mmHg, white blood 
cell count < 4 x 109 cells/mm3 or > 30 x 109 cells/mm3, urea > 7 
mmol/l, and albumin < 30 mmol/l.  Patients who were treated 
for pneumocystic pneumonia (PCP) or pulmonary tuberculosis 
(PTB) were excluded.
Statistical analysis
Length of stay in days and in-hospital mortality rates were 
compared between patients whose antimicrobial therapy for 
severe CAP was consistent with and inconsistent with South 
African guidelines respectively.  The unpaired t-test and 
Fisher’s exact test were used in analysing the data.  
Results
Four hundred and thirty inpatients with CAP were recruited.  
One hundred and eighty-two fulfilled the study criteria.  One 
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Objective. To evaluate adherence to the South African guidelines 
for the management of community-acquired pneumonia 
(CAP) and to determine whether adherence reduced length of 
hospital stay and mortality in patients with severe CAP.  
Setting. King Edward VIII Hospital, Durban.
Methods. Four hundred and thirty patients with CAP were 
recruited between June 2000 and October 2001.  Severity 
assessment data were collected. Severe CAP was defined by the 
presence of two or more markers. Without influence from the 
investigators, the admitting team chose the empirical antibiotic 
regimen. Antibiotics administered, outcome and length of stay 
were analysed. 
Results. Two hundred and eighty-seven of 430 patients were 
eligible for analysis. One hundred and eighty-two patients 
had two or more markers of severe CAP. Fourteen of the 
182 patients (8%) had initial antibiotic therapy administered 
according to South African guidelines and 168 (92%) did not. 
The mortality rate was 20% (36 patients).  Accounting for 
sample size there was no statistically significant difference 
in length of stay between the two groups (14 v. 12 days, p = 
1.0000, odds ratio (OR) 1.167, 95% confidence interval (CI): 
0.3926 - 3.467) or in mortality rate (28.5% v. 19%, p = 0.3549, OR 
1.667, 95% CI: 0.667 - 4.161). 
Conclusion. There was very poor adherence with South African 
CAP antibiotic guidelines. The sample size of patients receiving 
treatment according to the South African Thoracic Society 
(SATS) guidelines was too low to confirm confidently that 
adherence may have resulted in a clinical benefit.
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hundred and fifty-three of the 182 patients (84%) were HIV 
infected. The excluded 248 patients did not meet the criteria 
for severe disease, or had proven Mycobacterium tuberculosis, 
PCP, fungal pneumonia or were being treated empirically for 
PCP or PTB. The proportion of patients with each parameter 
considered as a marker of severe disease were: age > 60 years 
(2% of patients), co-morbid disease (9%), confusion (0%), 
hypotension (1%), involvement of 2 or more lobes (58%), 
respiratory rate ≥ 30 breaths/min (59%), temperature ≥ 38.3oC 
(53%), partial pressure of arterial oxygen < 60 mmHg (8%), 
white cell count < 4 x 109 cells/mm3 or > 30 x 109 cells/mm3 
(9%), urea > 7 mmol/l (49%) and albumin < 30 mmol/l (82%). 
A total of 113 bacterial isolates were identified, 50% of these 
were Streptococcus pneumoniae. Atypical pathogens accounted 
for 21% of isolates.  
Empirical antibiotic treatment for severe CAP consistent with 
South African guidelines was administered to 14 patients (8%) 
only.  The remaining 168 patients (92%) were given treatment 
that was inconsistent with the guidelines.  In the cohort of 
patients in whom the guidelines were followed, 9 subjects 
received intravenous second-generation cephalosporin and 
an aminoglycoside, 4 patients had intravenous amoxicillin-
clavulanic acid and an aminoglycoside, and 1 patient received 
intravenous second-generation cephalosporin and a macrolide. 
In the cohort in which the guidelines were not followed, 
antibiotic regimens administered were as shown in Table I.
Thirty-six patients died, resulting in an overall mortality rate 
of 20%.  Four patients (28.5%) died in the group that received 
treatment consistent with the South African guidelines while 
32 patients (19%) died in the cohort whose antibiotic regimens 
were not consistent with the guidelines.  The difference in 
mortality was not statistically significant (p = 0.7106).
There was no statistically significant difference in the mean 
length of hospital stay between the group in which the initial 
empirical antibiotic therapy was consistent with South African 
guidelines and the group in which the guidelines were not 
adhered to (14 days and 95% CI:  9.7 - 18.2 days v. 11.7 days 
and 95% CI:  10.3 - 13.1 days, p = 0.3995).
Discussion
This study is the first to analyse the impact that South African 
CAP guidelines have had on physician practice, length of 
stay and mortality at a tertiary hospital. Most patients with 
severe CAP were treated with antibiotic regimens that were 
inconsistent with South African guidelines (92%). The majority 
of cases were treated with a second-generation cephalosporin 
alone (50.5%), intravenous penicillin alone (17%), or 
intravenous amoxycillin-clavulanic acid. There was virtually 
no cover for Mycoplasma pneumoniae, Chlamydia pneumoniae 
and Legionella pneumophila except in 1 patient who received 
a second-generation cephalosporin and a macrolide.  The 
practice of not covering for the so-called ‘atypical’ pathogens 
probably stems from lack of clear evidence as to whether 
they are common pathogens or not in patients with CAP in 
South Africa.11,12 In this study M. pneumoniae, C. pneumoniae 
and L. pneumophila accounted for 13%, 8% and 1% of isolates 
respectively.  
There was no statistically significant difference in the length 
of hospital stay between the two cohorts. However, as only 
14 of 182 patients were treated according to guidelines, the 
sample size may be too small to detect meaningful difference. 
The length of stay in both groups (14 days and 12 days 
respectively) is a reflection of the severity of illness combined 
with socio-economic deprivation.  Besides the severity of 
illness, the high HIV seropositivity rate of 84% is an important 
consideration.  Patients tend to have a multiplicity of problems 
such as wasting, general debilitation and dehydration.  
Mortality was 28.5% and 19% in the patients who were 
given treatment consistent with and inconsistent with South 
African guidelines respectively.  Although the group in which 
the guidelines were not followed appeared to have had a better 
outcome, this difference did not reach statistical significance  
(p = 0.7106). One factor that might have influenced these results 
is the small number of patients in the group who received 
treatment according to the published guidelines.  A potential 
weakness of this study was the non-application of multiple 
logistical regression models to the confounding variable to 
Table I. Physicians’ antibiotic choices in the cohort of patients whose antibiotic regimens were not consistent with the South 
African guidelines (N = 168)
Antibiotic choice      Number of patients    %
IV 2nd-generation cephalosporin ± fluoroquinolone               86    51
IV penicillin G ± fluoroquinolone/chloramphenicol/ 
aminoglycoside                   38    23
IV amoxicillin-clavulanic acid ± fluoroquinolone                29    17
IV 3rd-generation cephalosporin ± IV flucloxacillin                 8      5
Oral amoxicillin/erythromycin ± metronidazole                  5      3
IV piperacillin and aminoglycoside/fluoroquinolone                 2      1
IV = intravenous.
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adjust for the differences in mortality and length of stay in the 
two groups. 
The study has shown that the South African guidelines have 
failed to significantly influence medical practice at a tertiary 
teaching hospital.  There are several possible explanations.3,6,8 
These include lack of awareness, attitude, lack of knowledge 
of the guidelines and local barriers to implementation 
of the guidelines.  In addition, physicians may feel that 
guidelines restrict their autonomy, freedom and clinical 
judgement.  Possible solutions include continuing medical 
education, feedback and physicians’ participation in efforts 
to have guidelines adopted and implemented, participation 
of administrators as well as regular guideline revision and 
auditing.  Guidelines need to be flexible and to be scientifically 
validated.
This study brings into focus the issue of institutional policy 
regarding the use of antimicrobials. There is no institutional 
policy on the use of antibiotics in CAP within the medical 
domain at King Edward VIII Hospital. The failure to provide 
clear policy may be owing to various reasons including 
ignorance of the need for and advantages of well-formulated 
policies, fear of alienating professionals, a lack of or shortage 
of good managers, inadequate financial resources which 
might make such policies unworkable, and bureaucratic and 
political interference.  Sound working relationships between 
institutional managers and clinicians are necessary for any 
policy to work. Erratic supplies of drugs would render any 
institutional policies unworkable. In the light of the data 
on compliance from this study, it is important to get some 
feedback from the clinicians regarding guidelines in general 
and the CAP guidelines in particular. This could be a follow-
up study in the form of a questionnaire. Valuable data on 
knowledge, attitudes, fears, concerns and antibiotic practising 
habits could emanate from such a study. The study could 
provide answers for the poor adherence to the guidelines.
The South African Thoracic Society (SATS) CAP guidelines 
were recently revised.13 Clear, workable strategies need to 
be devised to disseminate these guidelines to practising 
clinicians in an efficient and cost-effective manner. If the data 
from this study is a reflection of practice country-wide, a lot 
of work would be required to change physicians’ practising 
habits. Although it may be argued that mortality is not 
necessarily altered by following guidelines, there are equally 
compelling reasons for the issue of guidelines to be pursued 
vigorously. These are cost effectiveness, rational prescribing 
and minimising the development of antibiotic resistance, 
among other reasons. Lastly, the revised SATS CAP guidelines 
emphasise the emergence of tuberculosis and PCP as common 
pathogens in the light of the HIV epidemic. 
In conclusion, we have shown poor adherence to the CAP 
guidelines. A larger national multicentre study is required to 
validate current guidelines. Future studies should also focus on 
the reasons for non-compliance and the economic implications.
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